Clinical Trial

Healthcare Integrity & Anti-Fraud Enforcement

Study acronym: PHX-AFK-US
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The PHX-AFK-US Protocol is a coalition-backed regulatory scaffold designed to restore healthcare integrity across U.S. facilities. It targets fraud, kickback schemes, and supply chain opacity through validator governance, smart contract enforcement, and public transparency. Anchored by notarized affidavits, NFT fiscal instruments, and dashboard oversight, this protocol empowers whistleblowers, mobilizes validators, and escalates complaints to federal and state regulators. It integrates secure audit trails, DAO voting logic, and asset freeze triggers to ensure accountability, reform, and systemic trust.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-10-14.
Trial Details
NCT Number NCT07217730
Lead Sponsor Truway Health, Inc.
Conditions Healthcare Fraud Schemes, Kickback Networks, Supply Chain Vulnerabilities, Governance Failures, Whistleblower Activation, Regulatory Escalation Pathways, Validator Oversight & DAO Governance, Public Transparency & Auditability
Enrollment 100 participants
Start Date 2025-10-13
Primary Completion 2034-10-13 (estimated)
Study Completion 2034-10-13 (estimated)
Updated on ClinicalTrials.gov 2025-10-20